Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Ruboxistaurin Mesylate (LY333531) on Small Fiber Function as Measured by Microvascular Skin Blood Flow, C-Fiber Quantitations in Skin and Quantitative Sensory Testing of Cold and Heat.

NCT00190970 is registered in ClinicalTrials.gov with Chromaderm, Inc. as lead sponsor.

NCT NCT00190970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00190970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Ruboxistaurin Mesylate (LY333531) on Small Fiber Function as Measured by Microvascular Skin Blood Flow, C-Fiber Quantitations in Skin and Quantitative Sensory Testing of Cold and Heat.
Lead sponsor
Chromaderm, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2004
Completion date
November 30, 2005
Enrollment
52
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy